8/10/2021.

iToBoS project has been presented in Hungary with the article “Mesterséges intelligenciát használó eszköz készül a melanóma korai felismerésére”.

3/10/2021.

EADV (European Academy of Dermatology and Venereology) is the leading community to further the knowledge of health professionals and advocates in the field of dermatology and venereology. It is dedicated to advancing patient care, education and research in the field of dermatology and venereology by providing a unique platform to bring people together and share ideas.

30/09/2021.

iToBoS project and its Clinical Data Acquisition Study have been presented in the Good Clinical Practice Network.

29/09/2021.

The deliverable “D4.4 First Data management plan aligned with FAIR principles and other initiatives including RDA and EOSC” has been successfully submitted. This report is focused on the data that will be collected or processed by the iToBoS project: how they will be processed and protected through the compliance with recognised standards and regulations.

25/09/2021.

Since the publication of content grows day by day, an improved model of organization has been established on the website to make it easier for our audience to find content better.

22/09/2021.

The Project Management Board, with the leaders representating all work packages, held a plenary meeting to analyse the status and the progress of iToBoS, as well as to verify its alignment with the established roadmap.

18/09/2021.

Intelligent Total Body Scanner (iToBoS) System is a larger international project for developing an artificial intelligence (AI) assisted diagnostic platform for the early detection of melanoma. 

15/09/2021.

Skin cancer is one of the most common cancers in the world. The rate of skin cancer increased dramatically during the latest four decades and continues to rise in many places nowadays.

13/09/2021.

The iToBoS project held its first Advisory Board meeting.

10/09/2021.

Isahit is very proud to be part of iToBoS project and to contribute to making AI a real support for science and medicine.